224 related articles for article (PubMed ID: 19503102)
81. Peroxisome proliferator-activated receptor-α stimulation by clofibrate favors an antioxidant and vasodilator environment in a stressed left ventricle.
Ibarra-Lara L; Del Valle-Mondragón L; Soria-Castro E; Torres-Narváez JC; Pérez-Severiano F; Sánchez-Aguilar M; Ramírez-Ortega M; Cervantes-Pérez LG; Pastelín-Hernández GS; Oidor-Chan VH; Zarco-Olvera G; Sánchez-Mendoza A
Pharmacol Rep; 2016 Aug; 68(4):692-702. PubMed ID: 27110876
[TBL] [Abstract][Full Text] [Related]
82. The benefit of medium-chain triglyceride therapy on the cardiac function of SHRs is associated with a reversal of metabolic and signaling alterations.
Iemitsu M; Shimojo N; Maeda S; Irukayama-Tomobe Y; Sakai S; Ohkubo T; Tanaka Y; Miyauchi T
Am J Physiol Heart Circ Physiol; 2008 Jul; 295(1):H136-44. PubMed ID: 18456726
[TBL] [Abstract][Full Text] [Related]
83. Angiotensin converting enzyme inhibitors, left ventricular hypertrophy and fibrosis.
Linz W; Wiemer G; Schaper J; Zimmermann R; Nagasawa K; Gohlke P; Unger T; Schölkens BA
Mol Cell Biochem; 1995 Jun 7-21; 147(1-2):89-97. PubMed ID: 7494560
[TBL] [Abstract][Full Text] [Related]
84. [Bezafibrate up-regulate endothelial nitric oxide gene expressions via peroxisome proliferator-activated receptors alpha-dependent and independent pathways in cultured Bovine endothelial cells].
Wang Y; Wang Y; Wang DW
Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Jun; 34(6):530-6. PubMed ID: 16842672
[TBL] [Abstract][Full Text] [Related]
85. Raised blood pressure, not renin-angiotensin systems, causes cardiac fibrosis in TGR m(Ren2)27 rats.
Bishop JE; Kiernan LA; Montgomery HE; Gohlke P; McEwan JR
Cardiovasc Res; 2000 Jul; 47(1):57-67. PubMed ID: 10869530
[TBL] [Abstract][Full Text] [Related]
86. Beneficial effects of pioglitazone on hypertensive cardiovascular injury are enhanced by combination with candesartan.
Nakamura T; Yamamoto E; Kataoka K; Yamashita T; Tokutomi Y; Dong YF; Matsuba S; Ogawa H; Kim-Mitsuyama S
Hypertension; 2008 Feb; 51(2):296-301. PubMed ID: 18158350
[TBL] [Abstract][Full Text] [Related]
87. Lack of correlation of hypotensive effects with prevention of cardiac hypertrophy by perindopril after ligation of rat coronary artery.
Chiba K; Moriyama S; Ishigai Y; Fukuzawa A; Irie K; Shibano T
Br J Pharmacol; 1994 Jul; 112(3):837-42. PubMed ID: 7921610
[TBL] [Abstract][Full Text] [Related]
88. Effects of ERK1/2/PPARα/SCAD signal pathways on cardiomyocyte hypertrophy induced by insulin-like growth factor 1 and phenylephrine.
Huang Q; Huang J; Zeng Z; Luo J; Liu P; Chen S; Liu B; Pan X; Zang L; Zhou S
Life Sci; 2015 Mar; 124():41-9. PubMed ID: 25636810
[TBL] [Abstract][Full Text] [Related]
89. Attenuation of cardiac dysfunction by a PPAR-alpha agonist is associated with down-regulation of redox-regulated transcription factors.
Ichihara S; Obata K; Yamada Y; Nagata K; Noda A; Ichihara G; Yamada A; Kato T; Izawa H; Murohara T; Yokota M
J Mol Cell Cardiol; 2006 Aug; 41(2):318-29. PubMed ID: 16806263
[TBL] [Abstract][Full Text] [Related]
90. Combination renin-angiotensin system blockade and angiotensin-converting enzyme 2 in experimental myocardial infarction: implications for future therapeutic directions.
Burchill LJ; Velkoska E; Dean RG; Griggs K; Patel SK; Burrell LM
Clin Sci (Lond); 2012 Dec; 123(11):649-58. PubMed ID: 22715807
[TBL] [Abstract][Full Text] [Related]
91. Soluble epoxide hydrolase inhibition and peroxisome proliferator activated receptor γ agonist improve vascular function and decrease renal injury in hypertensive obese rats.
Imig JD; Walsh KA; Hye Khan MA; Nagasawa T; Cherian-Shaw M; Shaw SM; Hammock BD
Exp Biol Med (Maywood); 2012 Dec; 237(12):1402-12. PubMed ID: 23354399
[TBL] [Abstract][Full Text] [Related]
92. Telmisartan attenuates aortic hypertrophy in hypertensive rats by the modulation of ACE2 and profilin-1 expression.
Zhong JC; Ye JY; Jin HY; Yu X; Yu HM; Zhu DL; Gao PJ; Huang DY; Shuster M; Loibner H; Guo JM; Yu XY; Xiao BX; Gong ZH; Penninger JM; Oudit GY
Regul Pept; 2011 Jan; 166(1-3):90-7. PubMed ID: 20854846
[TBL] [Abstract][Full Text] [Related]
93. PPAR-gamma activation inhibits angiotensin II synthesis, apoptosis, and proliferation of mesangial cells from spontaneously hypertensive rats.
Efrati S; Berman S; Ilgiyeav E; Averbukh Z; Weissgarten J
Nephron Exp Nephrol; 2007; 106(4):e107-12. PubMed ID: 17622738
[TBL] [Abstract][Full Text] [Related]
94. MicroRNA-21 regulates peroxisome proliferator-activated receptor alpha, a molecular mechanism of cardiac pathology in Cardiorenal Syndrome Type 4.
Chuppa S; Liang M; Liu P; Liu Y; Casati MC; Cowley AW; Patullo L; Kriegel AJ
Kidney Int; 2018 Feb; 93(2):375-389. PubMed ID: 28760335
[TBL] [Abstract][Full Text] [Related]
95. MG53 Protects against Sepsis-Induced Myocardial Dysfunction by Upregulating Peroxisome Proliferator-Activated Receptor-
Han X; Chen D; Liufu N; Ji F; Zeng Q; Yao W; Cao M
Oxid Med Cell Longev; 2020; 2020():7413693. PubMed ID: 32908637
[TBL] [Abstract][Full Text] [Related]
96. [Protective effect of rosiglitazone on myocardium in diabetic cardiomyopathy of rats].
Lu YL; Wang YN; Zhang L; Zhu L; Zhao JB; Wu H; Wang NC; Wang XF; Yu DL
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2006 May; 35(3):245-50. PubMed ID: 16764024
[TBL] [Abstract][Full Text] [Related]
97. Cardiac dysfunction in adipose triglyceride lipase deficiency: treatment with a PPARα agonist.
Wölkart G; Schrammel A; Dörffel K; Haemmerle G; Zechner R; Mayer B
Br J Pharmacol; 2012 Jan; 165(2):380-9. PubMed ID: 21585347
[TBL] [Abstract][Full Text] [Related]
98. Resveratrol improves survival, hemodynamics and energetics in a rat model of hypertension leading to heart failure.
Rimbaud S; Ruiz M; Piquereau J; Mateo P; Fortin D; Veksler V; Garnier A; Ventura-Clapier R
PLoS One; 2011; 6(10):e26391. PubMed ID: 22028869
[TBL] [Abstract][Full Text] [Related]
99. A systems biology approach to understand the pathophysiological mechanisms of cardiac pathological hypertrophy associated with rosiglitazone.
Verschuren L; Wielinga PY; Kelder T; Radonjic M; Salic K; Kleemann R; van Ommen B; Kooistra T
BMC Med Genomics; 2014 Jun; 7():35. PubMed ID: 24938300
[TBL] [Abstract][Full Text] [Related]
100. C1q/tumor necrosis factor-related protein-3, a newly identified adipokine, is a novel antiapoptotic, proangiogenic, and cardioprotective molecule in the ischemic mouse heart.
Yi W; Sun Y; Yuan Y; Lau WB; Zheng Q; Wang X; Wang Y; Shang X; Gao E; Koch WJ; Ma XL
Circulation; 2012 Jun; 125(25):3159-69. PubMed ID: 22653084
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
